335 related articles for article (PubMed ID: 29703264)
1. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
[TBL] [Abstract][Full Text] [Related]
2. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
Fabis-Pedrini MJ; Bundell C; Wee CK; Lucas M; McLean-Tooke A; Mastaglia FL; Carroll WM; Kermode AG
J Neuroimmunol; 2018 Nov; 324():76-80. PubMed ID: 30248527
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation.
Shimizu M; Okuno T; Kinoshita M; Sumi H; Fujimura H; Yamashita K; Sugimoto T; Sakakibara S; Sakakibara K; Koda T; Tada S; Ishikura T; Murata H; Beppu S; Shiraishi N; Sugiyama Y; Nakatsuji Y; Kumanogoh A; Mochizuki H
Sci Rep; 2020 Aug; 10(1):13274. PubMed ID: 32764561
[TBL] [Abstract][Full Text] [Related]
5. CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.
Kaneko K; Sato DK; Nakashima I; Ogawa R; Akaishi T; Takai Y; Nishiyama S; Takahashi T; Misu T; Kuroda H; Tanaka S; Nomura K; Hashimoto Y; Callegaro D; Steinman L; Fujihara K; Aoki M
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):927-936. PubMed ID: 29875186
[TBL] [Abstract][Full Text] [Related]
6. Resolution of inflammation in neuromyelitis optica spectrum disorders.
Wang X; Jiao W; Lin M; Lu C; Liu C; Wang Y; Ma D; Wang X; Yin P; Feng J; Zhu J; Zhu M
Mult Scler Relat Disord; 2019 Jan; 27():34-41. PubMed ID: 30300851
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 level in cerebrospinal fluid of patients with neuromyelitis optica spectrum disorders: Increased levels and association with disease severity.
Peng Y; Chen J; Dai Y; Jiang Y; Qiu W; Gu Y; Wang H
Mult Scler Relat Disord; 2020 Apr; 39():101888. PubMed ID: 31869599
[TBL] [Abstract][Full Text] [Related]
8. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
[TBL] [Abstract][Full Text] [Related]
9. Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Chen H; Liu SM; Zhang XX; Liu YO; Li SZ; Liu Z; Dong HQ
Chin Med J (Engl); 2016 Sep; 129(17):2079-84. PubMed ID: 27569235
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid antibodies to aquaporin-4 in neuromyelitis optica and related disorders: frequency, origin, and diagnostic relevance.
Jarius S; Franciotta D; Paul F; Ruprecht K; Bergamaschi R; Rommer PS; Reuss R; Probst C; Kristoferitsch W; Wandinger KP; Wildemann B
J Neuroinflammation; 2010 Sep; 7():52. PubMed ID: 20825655
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.
Liu B; Zhong X; Lu Z; Qiu W; Hu X; Wang H
Neuroimmunomodulation; 2018; 25(4):185-192. PubMed ID: 30423585
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tuller F; Holzer H; Schanda K; Aboulenein-Djamshidian F; Höftberger R; Khalil M; Seifert-Held T; Leutmezer F; Berger T; Reindl M
J Neuroinflammation; 2016 Jul; 13(1):176. PubMed ID: 27371173
[TBL] [Abstract][Full Text] [Related]
14. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Sato DK; Callegaro D; de Haidar Jorge FM; Nakashima I; Nishiyama S; Takahashi T; Simm RF; Apostolos-Pereira SL; Misu T; Steinman L; Aoki M; Fujihara K
Ann Neurol; 2014 Aug; 76(2):305-9. PubMed ID: 24977390
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
Alves Do Rego C; Collongues N
Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
Yoshikura N; Kimura A; Hayashi Y; Inuzuka T
J Neuroimmunol; 2017 Sep; 310():150-157. PubMed ID: 28756870
[TBL] [Abstract][Full Text] [Related]
18. Plasma Homocysteine Level Is Associated with the Expanded Disability Status Scale in Neuromyelitis Optica Spectrum Disorder.
Liang J; Liu J; Fan R; Chen Z; Chen X; Tong J; Chen Y; Peng F; Jiang Y
Neuroimmunomodulation; 2019; 26(5):258-264. PubMed ID: 31655825
[TBL] [Abstract][Full Text] [Related]
19. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
20. EBI2-expressing B cells in neuromyelitis optica spectrum disorder with AQP4-IgG: Association with acute attacks and serum cytokines.
Baek SH; Kim B; Shin JY; Choi SJ; Ahn SH; Choi YS; Kim SM; Sung JJ
J Neuroimmunol; 2021 Sep; 358():577637. PubMed ID: 34229205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
